Concord Medical Services Holdings (Concord Medical Services Holdings) 3-Year Revenue Growth Rate : 30.20% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Concord Medical Services Holdings 3-Year Revenue Growth Rate?

Concord Medical Services Holdings's Revenue per Share for the six months ended in Dec. 2023 was $0.81.

During the past 12 months, Concord Medical Services Holdings's average Revenue per Share Growth Rate was 11.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 30.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 27.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was -4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Concord Medical Services Holdings was 39.80% per year. The lowest was -33.10% per year. And the median was 4.60% per year.

Competitive Comparison of Concord Medical Services Holdings's 3-Year Revenue Growth Rate

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Medical Services Holdings's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's 3-Year Revenue Growth Rate falls into.

Concord Medical Services Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Concord Medical Services Holdings (NYSE:CCM) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Concord Medical Services Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Concord Medical Services Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Medical Services Holdings (Concord Medical Services Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Medical Services Holdings Ltd (NYSE:CCM) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Room 2701-05 , 36 North Third Ring Road, Tower A, Global Trade Center, Dongcheng District, Beijing, CHN, 100013

Website

https://ir.ccm.cn

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers and diagnostic imaging centers and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.